Small-Molecule Far-Red Fluorescent Spray-on Probes Targeting Prostatic Acid Phosphatase for Fluorescence-Guided Surgery
Bioconjugate Chemistry · 10.11.2026
DOI: 10.1021/acs.bioconjchem.6c00469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 10.11.2026. Verfasst von Zachary Rabinowitz und 4 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute, Massachusetts General Hospital, CSB Development Fund.
Abstract (Originalsprache)
Fluorescence-guided surgery (FGS) is an emerging approach for real-time tumor visualization and surgical margin assessment, yet its application to prostate cancer remains limited by the scarcity of clinically relevant molecular targets and on-demand targeted imaging agents. Most molecularly targeted imaging strategies for prostate cancer have focused on prostate-specific membrane antigen (PSMA), underscoring the need for complementary targets that could enable fluorescence imaging across molecularly distinct disease subtypes. Here, we developed and systematically evaluated three far-red fluorescent probes targeting prostatic acid phosphatase (ACP3) by conjugating distinct fluorophores to a small-molecule ACP3 affinity ligand. We characterized the probes across biochemical, physicochemical, cellular, and tissue-based assays. Although all three probes retained nanomolar ACP3 inhibitor potency, ACP3i-SulfoCy5 exhibited the most favorable overall imaging profile, combining high aqueous solubility, low nonspecific retention, and superior tumor-to-background contrast in cellular and ex vivo tissue assays. In a PC3-ACP3 prostate tumor model, topical application of ACP3i-SulfoCy5 generated high-contrast fluorescence that clearly delineated tumor margins. Collectively, these findings establish ACP3 as a promising complementary target for prostate cancer fluorescence imaging and support further investigation of ACP3i-SulfoCy5 for topical fluorescence-guided imaging during prostate cancer surgery.
Förderung
- National Cancer Institute
- Massachusetts General Hospital
- CSB Development Fund
Zitieren
APA
Rabinowitz, Z., Deutsch-Williams, R. J., Simpson, G. G., Noguchi, S., & Weissleder, R. (2026). Small-Molecule Far-Red Fluorescent Spray-on Probes Targeting Prostatic Acid Phosphatase for Fluorescence-Guided Surgery. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00469
Vancouver
Rabinowitz Z, Deutsch-Williams RJ, Simpson GG, Noguchi S, Weissleder R. Small-Molecule Far-Red Fluorescent Spray-on Probes Targeting Prostatic Acid Phosphatase for Fluorescence-Guided Surgery. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00469
BibTeX
@article{Rabinowitz2026,
author = {Rabinowitz, Zachary and Deutsch-Williams, Riley J. and Simpson, Grant G. and Noguchi, Shingo and Weissleder, Ralph},
title = {Small-Molecule Far-Red Fluorescent Spray-on Probes Targeting Prostatic Acid Phosphatase for Fluorescence-Guided Surgery},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.6c00469}
}
EUVIMED